Skip to main content
An official website of the United States government

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Asefa, Mela
mela.asefa@nih.gov
240-276-6422
5E328 Program Support Assistant | Breast and Gynecologic Cancer
Program Support Assistant | Prostate and Urologic Cancer
House, Margaret, RN, B.S.N.
margaret.house@nih.gov
240-276-7047
5E306 Deputy Chief | Prostate and Urologic Cancer
Parnes, Howard L., M.D.
howard.parnes@nih.gov
240-276-7045
5E302 Chief | Prostate and Urologic Cancer

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies 5R33CA272321-03 Christos Patriotis, Ph.D., M.Sc.
Warner, Erica T

Massachusetts General Hospital
United States

Aspirins legacy on cancer and overall benefit: risk balance over a 15-year horizon 3U01CA301988-02S1 Asad Umar, D.V.M., Ph.D.
Washington, Karla

Washington University
United States

Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care 5R01CA258311-05 Brennan Streck, Ph.D., RN, M.P.H.
Watt, Gordon Patrick

Netherlands Cancer Institute
United States

Quantitative background parenchymal enhancement, measured on contrast-enhanced mammogram, as a novel marker of breast cancer risk 3R37CA284134-03S1 Claire Zhu, Ph.D.
Webster, Nicholas J

University Of California, San Diego
United States

Time-restricted feeding and breast cancer 5R01CA196853-09 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Webster, Nicholas J

Veterans Medical Research Fdn/San Diego
United States

The Effect of Time-Restricted Eating on the Efficiency of Chemo- and Hormonal-Therapy in Breast Cancer 5R21CA288777-02 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Wei, Lei

Roswell Park Cancer Institute Corp
United States

Advancing skin cancer prevention by tackling UV-induced clonogenic mutations 5R01CA255242-05 Wendy Wang, Ph.D., M.Sc.
Welsh, Joellen

State University Of New York At Albany
United States

Vitamin K: Body Pools and Function in Breast Cancer 5R01CA258231-05 Young Kim, Ph.D.
Whitman, Eric

Atlantic Health System, Inc.
United States

The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC Corp) 3UG1CA239772-06S1 Vanessa A. White, M.P.H.
Wildman-Tobriner, Benjamin

Duke University
United States

AI for Differentiation of Low vs High Risk Thyroid Nodules on Ultrasound 1R01CA297227-01A1 Wendy Wang, Ph.D., M.Sc.
Wilkin, Timothy J.

University Of California, San Diego
United States

Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub) 5UG1CA275414-05 Maria Silvina Frech, Ph.D., M.S.
Williams, Paige L

Harvard University D/B/A Harvard School Of Public Health
United States

Pediatric HIV/AIDS Cohort Study (PHACS) 2020 3P01HD103133-05S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Winer, Rachel L.

University Of Washington
United States

The CASCADE CLIMB: Cervical cancer prevention in women Living with HIV research Mobilization Base 5UG1CA275402-04 Maria Silvina Frech, Ph.D., M.S.
Winger, Joseph Giles

Duke University
United States

Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer 5R01CA291768-02 Brennan Streck, Ph.D., RN, M.P.H.
Winters-Stone, Kerri M

Oregon Health & Science University
United States

Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer 5R01CA248059-05 Goli Samimi, Ph.D., M.P.H.